Clauss developed a simple method for the quantitative determination of Fibrinogen by measuring the clotting time of dilute plasma after the addition of Thrombin. The clotting time is inversely proportional to the Fibrinogen concentration. The clotting time obtained in this manner is then compared with that of a standardised Fibrinogen preparation. The plasma must be diluted to provide a low level of potential inhibitors, e.g. FDP’s and Heparin. A strong Thrombin solution is utilised in order to ensure that the clotting time is independent of Thrombin concentration over a broad range.
Preparation of patients: Patients should be relaxed pre-venepuncture. Excessive stress and exercise will increase Factor VIII, vWF antigen and fibrinolysis. Veno-occlusion should be avoided.
Precautions: This test is not recommended for patients with active bleeding, acute infection or illness, or in those patients who have received blood transfusions within four weeks. Drugs that may increase Fibrinogen levels includec estrogens and oral contraceptives. Drugs that may cause decreased levels include anabolic steroids, androgens, Phenobarbital, Urokinase, Streptokinase, and Valproic acid.